ANTIGEN-SPECIFIC INDUCTION OF TOLERANCE
The invention relates to an immunogenic composition for sublingual, perlingual or oral administration, comprising at least an antigen and at least an adjuvant that is a bacterium selected from a Bifidobacterium and a lactic acid bacterium, or a combination of a corticosteroid with vitamin D3 or any...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to an immunogenic composition for sublingual, perlingual or oral administration, comprising at least an antigen and at least an adjuvant that is a bacterium selected from a Bifidobacterium and a lactic acid bacterium, or a combination of a corticosteroid with vitamin D3 or any metabolite or analog of the latter, in a pharmaceutically acceptable carrier that is suitable for sublingual, perlingual, or oral administration. Such compositions allow to elicit antigen-specific immune tolerance. |
---|---|
Bibliography: | Application Number: EP20160181540 |